Index by author

May 1, 2018; Volume 59,Issue 5

A

  1. Aulmann, Christoph

    1. Predictive Value of 18F-FDG PET in Patients with Advanced Medullary Thyroid Carcinoma Treated with Vandetanib
      Rudolf A. Werner, Jan-Stefan Schmid, Takahiro Higuchi, Mehrbod S. Javadi, Steven P. Rowe, Bruno Märkl, Christoph Aulmann, Martin Fassnacht, Matthias Kroiss, Christoph Reiners, Andreas K. Buck, Michael C. Kreissl and Constantin Lapa
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 756-761; DOI: https://doi.org/10.2967/jnumed.117.199778

B

  1. Bardiès, Manuel

    1. PSMA-Targeted Radionuclide Therapy and Salivary Gland Toxicity: Why Does It Matter?
      David Taïeb, Jean-Marc Foletti, Manuel Bardiès, Palma Rocchi, Rodney J. Hicks and Uwe Haberkorn
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 747-748; DOI: https://doi.org/10.2967/jnumed.118.207993

  2. Bathen, Tone F.

    1. Combined 18F-Fluciclovine PET/MRI Shows Potential for Detection and Characterization of High-Risk Prostate Cancer
      Mattijs Elschot, Kirsten M. Selnæs, Elise Sandsmark, Brage Krüger-Stokke, Øystein Størkersen, Guro F. Giskeødegård, May-Britt Tessem, Siver A. Moestue, Helena Bertilsson and Tone F. Bathen
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 762-768; DOI: https://doi.org/10.2967/jnumed.117.198598

  3. Baum, Richard P.

    1. 177Lu-3BP-227 for Neurotensin Receptor 1–Targeted Therapy of Metastatic Pancreatic Adenocarcinoma: First Clinical Results
      Richard P. Baum, Aviral Singh, Christiane Schuchardt, Harshad R. Kulkarni, Ingo Klette, Stefan Wiessalla, Frank Osterkamp, Ulrich Reineke and Christiane Smerling
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 809-814; DOI: https://doi.org/10.2967/jnumed.117.193847

  4. Bertilsson, Helena

    1. Combined 18F-Fluciclovine PET/MRI Shows Potential for Detection and Characterization of High-Risk Prostate Cancer
      Mattijs Elschot, Kirsten M. Selnæs, Elise Sandsmark, Brage Krüger-Stokke, Øystein Størkersen, Guro F. Giskeødegård, May-Britt Tessem, Siver A. Moestue, Helena Bertilsson and Tone F. Bathen
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 762-768; DOI: https://doi.org/10.2967/jnumed.117.198598

  5. Binse, Ina

    1. Radioactive Iodine Therapy for Differentiated Thyroid Cancer: Lessons from Confronting Controversial Literature on Risks for Secondary Malignancy
      Mark Tulchinsky, Ina Binse, Alfredo Campennì, Sabina Dizdarevic, Luca Giovanella, Ian Jong, Kalevi Kairemo and Chun K. Kim
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 723-725; DOI: https://doi.org/10.2967/jnumed.118.211359

  6. Boerman, Otto C.

    1. Digitalislike Compounds Restore hNIS Expression and Iodide Uptake Capacity in Anaplastic Thyroid Cancer
      Marika H. Tesselaar, Thomas Crezee, Imke Schuurmans, Danny Gerrits, James Nagarajah, Otto C. Boerman, Ilse van Engen–van Grunsven, Johannes W.A. Smit, Romana T. Netea–Maier and Theo S. Plantinga
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 780-786; DOI: https://doi.org/10.2967/jnumed.117.200675

  7. Bozin, Michael

    1. 18F-FDG–Avid Thyroid Incidentalomas: The Importance of Contextual Interpretation
      David A. Pattison, Michael Bozin, Alexandra Gorelik, Michael S. Hofman, Rodney J. Hicks and Anita Skandarajah
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 749-755; DOI: https://doi.org/10.2967/jnumed.117.198085

  8. Broski, Stephen M.

    1. 18F-FDG PET/CT in Erdheim–Chester Disease: Imaging Findings and Potential BRAF Mutation Biomarker
      Jason R. Young, Geoffrey B. Johnson, Robert C. Murphy, Ronald S. Go and Stephen M. Broski
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 774-779; DOI: https://doi.org/10.2967/jnumed.117.200741

  9. Brouwers, Adrienne H.

    1. Molecular Imaging in Cancer Drug Development
      Stijn J.H. Waaijer, Iris C. Kok, Bertha Eisses, Carolina P. Schröder, Mathilde Jalving, Adrienne H. Brouwers, Marjolijn N. Lub-de Hooge and Elisabeth G.E. de Vries
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 726-732; DOI: https://doi.org/10.2967/jnumed.116.188045

  10. Bruchertseifer, Frank

    1. Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with 225Ac-PSMA-617: Swimmer-Plot Analysis Suggests Efficacy Regarding Duration of Tumor Control
      Clemens Kratochwil, Frank Bruchertseifer, Hendrik Rathke, Markus Hohenfellner, Frederik L. Giesel, Uwe Haberkorn and Alfred Morgenstern
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 795-802; DOI: https://doi.org/10.2967/jnumed.117.203539

  11. Buck, Andreas K.

    1. Predictive Value of 18F-FDG PET in Patients with Advanced Medullary Thyroid Carcinoma Treated with Vandetanib
      Rudolf A. Werner, Jan-Stefan Schmid, Takahiro Higuchi, Mehrbod S. Javadi, Steven P. Rowe, Bruno Märkl, Christoph Aulmann, Martin Fassnacht, Matthias Kroiss, Christoph Reiners, Andreas K. Buck, Michael C. Kreissl and Constantin Lapa
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 756-761; DOI: https://doi.org/10.2967/jnumed.117.199778

C

  1. Calais, Jeremie

    1. Comparison of 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence
      Jeremie Calais, Wolfgang P. Fendler, Ken Herrmann, Matthias Eiber and Francesco Ceci
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 789-794; DOI: https://doi.org/10.2967/jnumed.117.203257
    2. Reply: Comparison of 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence: Prospective Trial Is on Its Way
      Jeremie Calais, Wolfgang Peter Fendler, Ken Herrmann, Matthias Eiber and Francesco Ceci
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 861; DOI: https://doi.org/10.2967/jnumed.118.209965

  2. Campennì, Alfredo

    1. Radioactive Iodine Therapy for Differentiated Thyroid Cancer: Lessons from Confronting Controversial Literature on Risks for Secondary Malignancy
      Mark Tulchinsky, Ina Binse, Alfredo Campennì, Sabina Dizdarevic, Luca Giovanella, Ian Jong, Kalevi Kairemo and Chun K. Kim
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 723-725; DOI: https://doi.org/10.2967/jnumed.118.211359

  3. Ceci, Francesco

    1. Comparison of 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence
      Jeremie Calais, Wolfgang P. Fendler, Ken Herrmann, Matthias Eiber and Francesco Ceci
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 789-794; DOI: https://doi.org/10.2967/jnumed.117.203257
    2. Aetna and 68Ga-DOTATATE: A Sequel to “The Injustice of Being Judged by the Errors of Others” ()
      Johannes Czernin and Francesco Ceci
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 721-722;
    3. Reply: Comparison of 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence: Prospective Trial Is on Its Way
      Jeremie Calais, Wolfgang Peter Fendler, Ken Herrmann, Matthias Eiber and Francesco Ceci
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 861; DOI: https://doi.org/10.2967/jnumed.118.209965

  4. Chan, Szeman Ruby

    1. Sex as a Biologic Variable in Preclinical Imaging Research: Initial Observations with 18F-FLT
      Szeman Ruby Chan, Kelley Salem, Justin Jeffery, Ginny L. Powers, Yongjun Yan, Kooresh I. Shoghi, Aparna M. Mahajan and Amy M. Fowler
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 833-838; DOI: https://doi.org/10.2967/jnumed.117.199406

  5. Chen, Xinyu

    1. Functional Renal Imaging with 2-Deoxy-2-18F-Fluorosorbitol PET in Rat Models of Renal Disorders
      Rudolf A. Werner, Hiroshi Wakabayashi, Xinyu Chen, Mitsuru Hirano, Tetsuya Shinaji, Constantin Lapa, Steven P. Rowe, Mehrbod S. Javadi and Takahiro Higuchi
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 828-832; DOI: https://doi.org/10.2967/jnumed.117.203828

  6. Cheon, Gi Jeong

    1. 18F-FEDAC as a Targeting Agent for Activated Macrophages in DBA/1 Mice with Collagen-Induced Arthritis: Comparison with 18F-FDG
      Seock-Jin Chung, Hai-Jeon Yoon, Hyewon Youn, Mi Jeong Kim, Yun-Sang Lee, Jae Min Jeong, June-Key Chung, Keon Wook Kang, Lin Xie, Ming-Rong Zhang and Gi Jeong Cheon
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 839-845; DOI: https://doi.org/10.2967/jnumed.117.200667

  7. Chung, June-Key

    1. 18F-FEDAC as a Targeting Agent for Activated Macrophages in DBA/1 Mice with Collagen-Induced Arthritis: Comparison with 18F-FDG
      Seock-Jin Chung, Hai-Jeon Yoon, Hyewon Youn, Mi Jeong Kim, Yun-Sang Lee, Jae Min Jeong, June-Key Chung, Keon Wook Kang, Lin Xie, Ming-Rong Zhang and Gi Jeong Cheon
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 839-845; DOI: https://doi.org/10.2967/jnumed.117.200667

  8. Chung, Seock-Jin

    1. 18F-FEDAC as a Targeting Agent for Activated Macrophages in DBA/1 Mice with Collagen-Induced Arthritis: Comparison with 18F-FDG
      Seock-Jin Chung, Hai-Jeon Yoon, Hyewon Youn, Mi Jeong Kim, Yun-Sang Lee, Jae Min Jeong, June-Key Chung, Keon Wook Kang, Lin Xie, Ming-Rong Zhang and Gi Jeong Cheon
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 839-845; DOI: https://doi.org/10.2967/jnumed.117.200667

  9. Crezee, Thomas

    1. Digitalislike Compounds Restore hNIS Expression and Iodide Uptake Capacity in Anaplastic Thyroid Cancer
      Marika H. Tesselaar, Thomas Crezee, Imke Schuurmans, Danny Gerrits, James Nagarajah, Otto C. Boerman, Ilse van Engen–van Grunsven, Johannes W.A. Smit, Romana T. Netea–Maier and Theo S. Plantinga
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 780-786; DOI: https://doi.org/10.2967/jnumed.117.200675

  10. Czernin, Johannes

    1. Aetna and 68Ga-DOTATATE: A Sequel to “The Injustice of Being Judged by the Errors of Others” ()
      Johannes Czernin and Francesco Ceci
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 721-722;

D

  1. Denes, Bela

    1. Comparison of 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence: Interesting, but Far from Definitive
      Bela Denes and Peter Gardiner
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 860; DOI: https://doi.org/10.2967/jnumed.118.209817

  2. De Toni, Enrico N.

    1. Prediction of 90Y Radioembolization Outcome from Pretherapeutic Factors with Random Survival Forests
      Michael Ingrisch, Franziska Schöppe, Karolin Paprottka, Matthias Fabritius, Frederik F. Strobl, Enrico N. De Toni, Harun Ilhan, Andrei Todica, Marlies Michl and Philipp Marius Paprottka
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 769-773; DOI: https://doi.org/10.2967/jnumed.117.200758

  3. de Vries, Elisabeth G.E.

    1. Molecular Imaging in Cancer Drug Development
      Stijn J.H. Waaijer, Iris C. Kok, Bertha Eisses, Carolina P. Schröder, Mathilde Jalving, Adrienne H. Brouwers, Marjolijn N. Lub-de Hooge and Elisabeth G.E. de Vries
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 726-732; DOI: https://doi.org/10.2967/jnumed.116.188045

  4. Dizdarevic, Sabina

    1. Radioactive Iodine Therapy for Differentiated Thyroid Cancer: Lessons from Confronting Controversial Literature on Risks for Secondary Malignancy
      Mark Tulchinsky, Ina Binse, Alfredo Campennì, Sabina Dizdarevic, Luca Giovanella, Ian Jong, Kalevi Kairemo and Chun K. Kim
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 723-725; DOI: https://doi.org/10.2967/jnumed.118.211359

E

  1. Eiber, Matthias

    1. Comparison of 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence
      Jeremie Calais, Wolfgang P. Fendler, Ken Herrmann, Matthias Eiber and Francesco Ceci
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 789-794; DOI: https://doi.org/10.2967/jnumed.117.203257
    2. Reply: Comparison of 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence: Prospective Trial Is on Its Way
      Jeremie Calais, Wolfgang Peter Fendler, Ken Herrmann, Matthias Eiber and Francesco Ceci
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 861; DOI: https://doi.org/10.2967/jnumed.118.209965

  2. Eisses, Bertha

    1. Molecular Imaging in Cancer Drug Development
      Stijn J.H. Waaijer, Iris C. Kok, Bertha Eisses, Carolina P. Schröder, Mathilde Jalving, Adrienne H. Brouwers, Marjolijn N. Lub-de Hooge and Elisabeth G.E. de Vries
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 726-732; DOI: https://doi.org/10.2967/jnumed.116.188045

  3. Elschot, Mattijs

    1. Combined 18F-Fluciclovine PET/MRI Shows Potential for Detection and Characterization of High-Risk Prostate Cancer
      Mattijs Elschot, Kirsten M. Selnæs, Elise Sandsmark, Brage Krüger-Stokke, Øystein Størkersen, Guro F. Giskeødegård, May-Britt Tessem, Siver A. Moestue, Helena Bertilsson and Tone F. Bathen
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 762-768; DOI: https://doi.org/10.2967/jnumed.117.198598

F

  1. Fabritius, Matthias

    1. Prediction of 90Y Radioembolization Outcome from Pretherapeutic Factors with Random Survival Forests
      Michael Ingrisch, Franziska Schöppe, Karolin Paprottka, Matthias Fabritius, Frederik F. Strobl, Enrico N. De Toni, Harun Ilhan, Andrei Todica, Marlies Michl and Philipp Marius Paprottka
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 769-773; DOI: https://doi.org/10.2967/jnumed.117.200758

  2. Fassnacht, Martin

    1. Predictive Value of 18F-FDG PET in Patients with Advanced Medullary Thyroid Carcinoma Treated with Vandetanib
      Rudolf A. Werner, Jan-Stefan Schmid, Takahiro Higuchi, Mehrbod S. Javadi, Steven P. Rowe, Bruno Märkl, Christoph Aulmann, Martin Fassnacht, Matthias Kroiss, Christoph Reiners, Andreas K. Buck, Michael C. Kreissl and Constantin Lapa
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 756-761; DOI: https://doi.org/10.2967/jnumed.117.199778

  3. Fendler, Wolfgang P.

    1. Comparison of 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence
      Jeremie Calais, Wolfgang P. Fendler, Ken Herrmann, Matthias Eiber and Francesco Ceci
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 789-794; DOI: https://doi.org/10.2967/jnumed.117.203257

  4. Fendler, Wolfgang Peter

    1. Reply: Comparison of 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence: Prospective Trial Is on Its Way
      Jeremie Calais, Wolfgang Peter Fendler, Ken Herrmann, Matthias Eiber and Francesco Ceci
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 861; DOI: https://doi.org/10.2967/jnumed.118.209965

  5. Foletti, Jean-Marc

    1. PSMA-Targeted Radionuclide Therapy and Salivary Gland Toxicity: Why Does It Matter?
      David Taïeb, Jean-Marc Foletti, Manuel Bardiès, Palma Rocchi, Rodney J. Hicks and Uwe Haberkorn
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 747-748; DOI: https://doi.org/10.2967/jnumed.118.207993

  6. Fowler, Amy M.

    1. Sex as a Biologic Variable in Preclinical Imaging Research: Initial Observations with 18F-FLT
      Szeman Ruby Chan, Kelley Salem, Justin Jeffery, Ginny L. Powers, Yongjun Yan, Kooresh I. Shoghi, Aparna M. Mahajan and Amy M. Fowler
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 833-838; DOI: https://doi.org/10.2967/jnumed.117.199406

  7. Fushimi, Yasutaka

    1. Comparison of PET/CT with Sequential PET/MRI Using an MR-Compatible Mobile PET System
      Ryusuke Nakamoto, Yuji Nakamoto, Takayoshi Ishimori, Yasutaka Fushimi, Aki Kido and Kaori Togashi
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 846-851; DOI: https://doi.org/10.2967/jnumed.117.197665

G

  1. Gambhir, Sanjiv S.

    1. Prospective Evaluation of 68Ga-RM2 PET/MRI in Patients with Biochemical Recurrence of Prostate Cancer and Negative Findings on Conventional Imaging
      Ryogo Minamimoto, Ida Sonni, Steven Hancock, Shreyas Vasanawala, Andreas Loening, Sanjiv S. Gambhir and Andrei Iagaru
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 803-808; DOI: https://doi.org/10.2967/jnumed.117.197624

  2. Gardiner, Peter

    1. Comparison of 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence: Interesting, but Far from Definitive
      Bela Denes and Peter Gardiner
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 860; DOI: https://doi.org/10.2967/jnumed.118.209817

  3. Gerrits, Danny

    1. Digitalislike Compounds Restore hNIS Expression and Iodide Uptake Capacity in Anaplastic Thyroid Cancer
      Marika H. Tesselaar, Thomas Crezee, Imke Schuurmans, Danny Gerrits, James Nagarajah, Otto C. Boerman, Ilse van Engen–van Grunsven, Johannes W.A. Smit, Romana T. Netea–Maier and Theo S. Plantinga
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 780-786; DOI: https://doi.org/10.2967/jnumed.117.200675

  4. Giesel, Frederik L.

    1. Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with 225Ac-PSMA-617: Swimmer-Plot Analysis Suggests Efficacy Regarding Duration of Tumor Control
      Clemens Kratochwil, Frank Bruchertseifer, Hendrik Rathke, Markus Hohenfellner, Frederik L. Giesel, Uwe Haberkorn and Alfred Morgenstern
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 795-802; DOI: https://doi.org/10.2967/jnumed.117.203539

  5. Giovanella, Luca

    1. Radioactive Iodine Therapy for Differentiated Thyroid Cancer: Lessons from Confronting Controversial Literature on Risks for Secondary Malignancy
      Mark Tulchinsky, Ina Binse, Alfredo Campennì, Sabina Dizdarevic, Luca Giovanella, Ian Jong, Kalevi Kairemo and Chun K. Kim
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 723-725; DOI: https://doi.org/10.2967/jnumed.118.211359

  6. Giskeødegård, Guro F.

    1. Combined 18F-Fluciclovine PET/MRI Shows Potential for Detection and Characterization of High-Risk Prostate Cancer
      Mattijs Elschot, Kirsten M. Selnæs, Elise Sandsmark, Brage Krüger-Stokke, Øystein Størkersen, Guro F. Giskeødegård, May-Britt Tessem, Siver A. Moestue, Helena Bertilsson and Tone F. Bathen
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 762-768; DOI: https://doi.org/10.2967/jnumed.117.198598

  7. Go, Ronald S.

    1. 18F-FDG PET/CT in Erdheim–Chester Disease: Imaging Findings and Potential BRAF Mutation Biomarker
      Jason R. Young, Geoffrey B. Johnson, Robert C. Murphy, Ronald S. Go and Stephen M. Broski
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 774-779; DOI: https://doi.org/10.2967/jnumed.117.200741

  8. Gorelik, Alexandra

    1. 18F-FDG–Avid Thyroid Incidentalomas: The Importance of Contextual Interpretation
      David A. Pattison, Michael Bozin, Alexandra Gorelik, Michael S. Hofman, Rodney J. Hicks and Anita Skandarajah
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 749-755; DOI: https://doi.org/10.2967/jnumed.117.198085

  9. Gorin, Michael A.

    1. Molecular Imaging of Prostate Cancer: Choosing the Right Agent
      Steven P. Rowe, Martin G. Pomper and Michael A. Gorin
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 787-788; DOI: https://doi.org/10.2967/jnumed.117.206318

  10. Gunn, Roger N.

    1. Spatiotemporal Distribution of β-Amyloid in Alzheimer Disease Is the Result of Heterogeneous Regional Carrying Capacities
      Alex Whittington, David J. Sharp and Roger N. Gunn; for the Alzheimer’s Disease Neuroimaging Initiative
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 822-827; DOI: https://doi.org/10.2967/jnumed.117.194720

H

  1. Haberkorn, Uwe

    1. Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with 225Ac-PSMA-617: Swimmer-Plot Analysis Suggests Efficacy Regarding Duration of Tumor Control
      Clemens Kratochwil, Frank Bruchertseifer, Hendrik Rathke, Markus Hohenfellner, Frederik L. Giesel, Uwe Haberkorn and Alfred Morgenstern
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 795-802; DOI: https://doi.org/10.2967/jnumed.117.203539
    2. PSMA-Targeted Radionuclide Therapy and Salivary Gland Toxicity: Why Does It Matter?
      David Taïeb, Jean-Marc Foletti, Manuel Bardiès, Palma Rocchi, Rodney J. Hicks and Uwe Haberkorn
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 747-748; DOI: https://doi.org/10.2967/jnumed.118.207993

  2. Hanaoka, Hirofumi

    1. Radiolabeled (4-Fluoro-3-Iodobenzyl)Guanidine Improves Imaging and Targeted Radionuclide Therapy of Norepinephrine Transporter–Expressing Tumors
      Aiko Yamaguchi, Hirofumi Hanaoka, Tetsuya Higuchi and Yoshito Tsushima
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 815-821; DOI: https://doi.org/10.2967/jnumed.117.201525

  3. Hancock, Steven

    1. Prospective Evaluation of 68Ga-RM2 PET/MRI in Patients with Biochemical Recurrence of Prostate Cancer and Negative Findings on Conventional Imaging
      Ryogo Minamimoto, Ida Sonni, Steven Hancock, Shreyas Vasanawala, Andreas Loening, Sanjiv S. Gambhir and Andrei Iagaru
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 803-808; DOI: https://doi.org/10.2967/jnumed.117.197624

  4. Herrmann, Ken

    1. Comparison of 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence
      Jeremie Calais, Wolfgang P. Fendler, Ken Herrmann, Matthias Eiber and Francesco Ceci
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 789-794; DOI: https://doi.org/10.2967/jnumed.117.203257
    2. Reply: Comparison of 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence: Prospective Trial Is on Its Way
      Jeremie Calais, Wolfgang Peter Fendler, Ken Herrmann, Matthias Eiber and Francesco Ceci
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 861; DOI: https://doi.org/10.2967/jnumed.118.209965

  5. Hicks, Rodney J.

    1. PSMA-Targeted Radionuclide Therapy and Salivary Gland Toxicity: Why Does It Matter?
      David Taïeb, Jean-Marc Foletti, Manuel Bardiès, Palma Rocchi, Rodney J. Hicks and Uwe Haberkorn
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 747-748; DOI: https://doi.org/10.2967/jnumed.118.207993
    2. 18F-FDG–Avid Thyroid Incidentalomas: The Importance of Contextual Interpretation
      David A. Pattison, Michael Bozin, Alexandra Gorelik, Michael S. Hofman, Rodney J. Hicks and Anita Skandarajah
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 749-755; DOI: https://doi.org/10.2967/jnumed.117.198085

  6. Higuchi, Takahiro

    1. Predictive Value of 18F-FDG PET in Patients with Advanced Medullary Thyroid Carcinoma Treated with Vandetanib
      Rudolf A. Werner, Jan-Stefan Schmid, Takahiro Higuchi, Mehrbod S. Javadi, Steven P. Rowe, Bruno Märkl, Christoph Aulmann, Martin Fassnacht, Matthias Kroiss, Christoph Reiners, Andreas K. Buck, Michael C. Kreissl and Constantin Lapa
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 756-761; DOI: https://doi.org/10.2967/jnumed.117.199778
    2. Functional Renal Imaging with 2-Deoxy-2-18F-Fluorosorbitol PET in Rat Models of Renal Disorders
      Rudolf A. Werner, Hiroshi Wakabayashi, Xinyu Chen, Mitsuru Hirano, Tetsuya Shinaji, Constantin Lapa, Steven P. Rowe, Mehrbod S. Javadi and Takahiro Higuchi
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 828-832; DOI: https://doi.org/10.2967/jnumed.117.203828

  7. Higuchi, Tetsuya

    1. Radiolabeled (4-Fluoro-3-Iodobenzyl)Guanidine Improves Imaging and Targeted Radionuclide Therapy of Norepinephrine Transporter–Expressing Tumors
      Aiko Yamaguchi, Hirofumi Hanaoka, Tetsuya Higuchi and Yoshito Tsushima
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 815-821; DOI: https://doi.org/10.2967/jnumed.117.201525

  8. Hirano, Mitsuru

    1. Functional Renal Imaging with 2-Deoxy-2-18F-Fluorosorbitol PET in Rat Models of Renal Disorders
      Rudolf A. Werner, Hiroshi Wakabayashi, Xinyu Chen, Mitsuru Hirano, Tetsuya Shinaji, Constantin Lapa, Steven P. Rowe, Mehrbod S. Javadi and Takahiro Higuchi
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 828-832; DOI: https://doi.org/10.2967/jnumed.117.203828

  9. Hofman, Michael S.

    1. 18F-FDG–Avid Thyroid Incidentalomas: The Importance of Contextual Interpretation
      David A. Pattison, Michael Bozin, Alexandra Gorelik, Michael S. Hofman, Rodney J. Hicks and Anita Skandarajah
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 749-755; DOI: https://doi.org/10.2967/jnumed.117.198085

  10. Hohenfellner, Markus

    1. Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with 225Ac-PSMA-617: Swimmer-Plot Analysis Suggests Efficacy Regarding Duration of Tumor Control
      Clemens Kratochwil, Frank Bruchertseifer, Hendrik Rathke, Markus Hohenfellner, Frederik L. Giesel, Uwe Haberkorn and Alfred Morgenstern
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 795-802; DOI: https://doi.org/10.2967/jnumed.117.203539

  11. Hope, Thomas A.

    1. Zero-Echo-Time and Dixon Deep Pseudo-CT (ZeDD CT): Direct Generation of Pseudo-CT Images for Pelvic PET/MRI Attenuation Correction Using Deep Convolutional Neural Networks with Multiparametric MRI
      Andrew P. Leynes, Jaewon Yang, Florian Wiesinger, Sandeep S. Kaushik, Dattesh D. Shanbhag, Youngho Seo, Thomas A. Hope and Peder E.Z. Larson
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 852-858; DOI: https://doi.org/10.2967/jnumed.117.198051

  12. Howell, Roger W.

    1. Wessels to Be Recognized with Loevinger–Berman Award
      Roger W. Howell and George Sgouros; on behalf of the SNMMI Medical Internal Radiation Dose Committee
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 9N-10N;

I

  1. Iagaru, Andrei

    1. Prospective Evaluation of 68Ga-RM2 PET/MRI in Patients with Biochemical Recurrence of Prostate Cancer and Negative Findings on Conventional Imaging
      Ryogo Minamimoto, Ida Sonni, Steven Hancock, Shreyas Vasanawala, Andreas Loening, Sanjiv S. Gambhir and Andrei Iagaru
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 803-808; DOI: https://doi.org/10.2967/jnumed.117.197624

  2. Ilhan, Harun

    1. Prediction of 90Y Radioembolization Outcome from Pretherapeutic Factors with Random Survival Forests
      Michael Ingrisch, Franziska Schöppe, Karolin Paprottka, Matthias Fabritius, Frederik F. Strobl, Enrico N. De Toni, Harun Ilhan, Andrei Todica, Marlies Michl and Philipp Marius Paprottka
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 769-773; DOI: https://doi.org/10.2967/jnumed.117.200758

  3. Ingrisch, Michael

    1. Prediction of 90Y Radioembolization Outcome from Pretherapeutic Factors with Random Survival Forests
      Michael Ingrisch, Franziska Schöppe, Karolin Paprottka, Matthias Fabritius, Frederik F. Strobl, Enrico N. De Toni, Harun Ilhan, Andrei Todica, Marlies Michl and Philipp Marius Paprottka
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 769-773; DOI: https://doi.org/10.2967/jnumed.117.200758

  4. Ishimori, Takayoshi

    1. Comparison of PET/CT with Sequential PET/MRI Using an MR-Compatible Mobile PET System
      Ryusuke Nakamoto, Yuji Nakamoto, Takayoshi Ishimori, Yasutaka Fushimi, Aki Kido and Kaori Togashi
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 846-851; DOI: https://doi.org/10.2967/jnumed.117.197665

J

  1. Jalving, Mathilde

    1. Molecular Imaging in Cancer Drug Development
      Stijn J.H. Waaijer, Iris C. Kok, Bertha Eisses, Carolina P. Schröder, Mathilde Jalving, Adrienne H. Brouwers, Marjolijn N. Lub-de Hooge and Elisabeth G.E. de Vries
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 726-732; DOI: https://doi.org/10.2967/jnumed.116.188045

  2. Javadi, Mehrbod S.

    1. Predictive Value of 18F-FDG PET in Patients with Advanced Medullary Thyroid Carcinoma Treated with Vandetanib
      Rudolf A. Werner, Jan-Stefan Schmid, Takahiro Higuchi, Mehrbod S. Javadi, Steven P. Rowe, Bruno Märkl, Christoph Aulmann, Martin Fassnacht, Matthias Kroiss, Christoph Reiners, Andreas K. Buck, Michael C. Kreissl and Constantin Lapa
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 756-761; DOI: https://doi.org/10.2967/jnumed.117.199778
    2. Functional Renal Imaging with 2-Deoxy-2-18F-Fluorosorbitol PET in Rat Models of Renal Disorders
      Rudolf A. Werner, Hiroshi Wakabayashi, Xinyu Chen, Mitsuru Hirano, Tetsuya Shinaji, Constantin Lapa, Steven P. Rowe, Mehrbod S. Javadi and Takahiro Higuchi
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 828-832; DOI: https://doi.org/10.2967/jnumed.117.203828

  3. Jeffery, Justin

    1. Sex as a Biologic Variable in Preclinical Imaging Research: Initial Observations with 18F-FLT
      Szeman Ruby Chan, Kelley Salem, Justin Jeffery, Ginny L. Powers, Yongjun Yan, Kooresh I. Shoghi, Aparna M. Mahajan and Amy M. Fowler
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 833-838; DOI: https://doi.org/10.2967/jnumed.117.199406

  4. Jeong, Jae Min

    1. 18F-FEDAC as a Targeting Agent for Activated Macrophages in DBA/1 Mice with Collagen-Induced Arthritis: Comparison with 18F-FDG
      Seock-Jin Chung, Hai-Jeon Yoon, Hyewon Youn, Mi Jeong Kim, Yun-Sang Lee, Jae Min Jeong, June-Key Chung, Keon Wook Kang, Lin Xie, Ming-Rong Zhang and Gi Jeong Cheon
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 839-845; DOI: https://doi.org/10.2967/jnumed.117.200667

  5. Johnson, Geoffrey B.

    1. 18F-FDG PET/CT in Erdheim–Chester Disease: Imaging Findings and Potential BRAF Mutation Biomarker
      Jason R. Young, Geoffrey B. Johnson, Robert C. Murphy, Ronald S. Go and Stephen M. Broski
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 774-779; DOI: https://doi.org/10.2967/jnumed.117.200741

  6. Jong, Ian

    1. Radioactive Iodine Therapy for Differentiated Thyroid Cancer: Lessons from Confronting Controversial Literature on Risks for Secondary Malignancy
      Mark Tulchinsky, Ina Binse, Alfredo Campennì, Sabina Dizdarevic, Luca Giovanella, Ian Jong, Kalevi Kairemo and Chun K. Kim
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 723-725; DOI: https://doi.org/10.2967/jnumed.118.211359

K

  1. Kairemo, Kalevi

    1. Radioactive Iodine Therapy for Differentiated Thyroid Cancer: Lessons from Confronting Controversial Literature on Risks for Secondary Malignancy
      Mark Tulchinsky, Ina Binse, Alfredo Campennì, Sabina Dizdarevic, Luca Giovanella, Ian Jong, Kalevi Kairemo and Chun K. Kim
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 723-725; DOI: https://doi.org/10.2967/jnumed.118.211359

  2. Kang, Keon Wook

    1. 18F-FEDAC as a Targeting Agent for Activated Macrophages in DBA/1 Mice with Collagen-Induced Arthritis: Comparison with 18F-FDG
      Seock-Jin Chung, Hai-Jeon Yoon, Hyewon Youn, Mi Jeong Kim, Yun-Sang Lee, Jae Min Jeong, June-Key Chung, Keon Wook Kang, Lin Xie, Ming-Rong Zhang and Gi Jeong Cheon
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 839-845; DOI: https://doi.org/10.2967/jnumed.117.200667

  3. Kaushik, Sandeep S.

    1. Zero-Echo-Time and Dixon Deep Pseudo-CT (ZeDD CT): Direct Generation of Pseudo-CT Images for Pelvic PET/MRI Attenuation Correction Using Deep Convolutional Neural Networks with Multiparametric MRI
      Andrew P. Leynes, Jaewon Yang, Florian Wiesinger, Sandeep S. Kaushik, Dattesh D. Shanbhag, Youngho Seo, Thomas A. Hope and Peder E.Z. Larson
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 852-858; DOI: https://doi.org/10.2967/jnumed.117.198051

  4. Kido, Aki

    1. Comparison of PET/CT with Sequential PET/MRI Using an MR-Compatible Mobile PET System
      Ryusuke Nakamoto, Yuji Nakamoto, Takayoshi Ishimori, Yasutaka Fushimi, Aki Kido and Kaori Togashi
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 846-851; DOI: https://doi.org/10.2967/jnumed.117.197665

  5. Kiessling, Fabian

    1. Advanced Ultrasound Technologies for Diagnosis and Therapy
      Anne Rix, Wiltrud Lederle, Benjamin Theek, Twan Lammers, Chrit Moonen, Georg Schmitz and Fabian Kiessling
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 740-746; DOI: https://doi.org/10.2967/jnumed.117.200030

  6. Kim, Chun K.

    1. Radioactive Iodine Therapy for Differentiated Thyroid Cancer: Lessons from Confronting Controversial Literature on Risks for Secondary Malignancy
      Mark Tulchinsky, Ina Binse, Alfredo Campennì, Sabina Dizdarevic, Luca Giovanella, Ian Jong, Kalevi Kairemo and Chun K. Kim
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 723-725; DOI: https://doi.org/10.2967/jnumed.118.211359

  7. Kim, E. Edmund

    1. Molecular Imaging: An Introduction
      E. Edmund Kim
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 859; DOI: https://doi.org/10.2967/jnumed.118.209635

  8. Kim, Mi Jeong

    1. 18F-FEDAC as a Targeting Agent for Activated Macrophages in DBA/1 Mice with Collagen-Induced Arthritis: Comparison with 18F-FDG
      Seock-Jin Chung, Hai-Jeon Yoon, Hyewon Youn, Mi Jeong Kim, Yun-Sang Lee, Jae Min Jeong, June-Key Chung, Keon Wook Kang, Lin Xie, Ming-Rong Zhang and Gi Jeong Cheon
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 839-845; DOI: https://doi.org/10.2967/jnumed.117.200667

  9. Klette, Ingo

    1. 177Lu-3BP-227 for Neurotensin Receptor 1–Targeted Therapy of Metastatic Pancreatic Adenocarcinoma: First Clinical Results
      Richard P. Baum, Aviral Singh, Christiane Schuchardt, Harshad R. Kulkarni, Ingo Klette, Stefan Wiessalla, Frank Osterkamp, Ulrich Reineke and Christiane Smerling
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 809-814; DOI: https://doi.org/10.2967/jnumed.117.193847

  10. Kok, Iris C.

    1. Molecular Imaging in Cancer Drug Development
      Stijn J.H. Waaijer, Iris C. Kok, Bertha Eisses, Carolina P. Schröder, Mathilde Jalving, Adrienne H. Brouwers, Marjolijn N. Lub-de Hooge and Elisabeth G.E. de Vries
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 726-732; DOI: https://doi.org/10.2967/jnumed.116.188045

  11. Kratochwil, Clemens

    1. Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with 225Ac-PSMA-617: Swimmer-Plot Analysis Suggests Efficacy Regarding Duration of Tumor Control
      Clemens Kratochwil, Frank Bruchertseifer, Hendrik Rathke, Markus Hohenfellner, Frederik L. Giesel, Uwe Haberkorn and Alfred Morgenstern
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 795-802; DOI: https://doi.org/10.2967/jnumed.117.203539

  12. Kreissl, Michael C.

    1. Predictive Value of 18F-FDG PET in Patients with Advanced Medullary Thyroid Carcinoma Treated with Vandetanib
      Rudolf A. Werner, Jan-Stefan Schmid, Takahiro Higuchi, Mehrbod S. Javadi, Steven P. Rowe, Bruno Märkl, Christoph Aulmann, Martin Fassnacht, Matthias Kroiss, Christoph Reiners, Andreas K. Buck, Michael C. Kreissl and Constantin Lapa
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 756-761; DOI: https://doi.org/10.2967/jnumed.117.199778

  13. Kroiss, Matthias

    1. Predictive Value of 18F-FDG PET in Patients with Advanced Medullary Thyroid Carcinoma Treated with Vandetanib
      Rudolf A. Werner, Jan-Stefan Schmid, Takahiro Higuchi, Mehrbod S. Javadi, Steven P. Rowe, Bruno Märkl, Christoph Aulmann, Martin Fassnacht, Matthias Kroiss, Christoph Reiners, Andreas K. Buck, Michael C. Kreissl and Constantin Lapa
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 756-761; DOI: https://doi.org/10.2967/jnumed.117.199778

  14. Krüger-Stokke, Brage

    1. Combined 18F-Fluciclovine PET/MRI Shows Potential for Detection and Characterization of High-Risk Prostate Cancer
      Mattijs Elschot, Kirsten M. Selnæs, Elise Sandsmark, Brage Krüger-Stokke, Øystein Størkersen, Guro F. Giskeødegård, May-Britt Tessem, Siver A. Moestue, Helena Bertilsson and Tone F. Bathen
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 762-768; DOI: https://doi.org/10.2967/jnumed.117.198598

  15. Kubler, Caitlin B.

    1. NRC Advisory Committee on Medical Uses of Isotopes Spring Meeting
      Caitlin B. Kubler
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 7N;

  16. Kulkarni, Harshad R.

    1. 177Lu-3BP-227 for Neurotensin Receptor 1–Targeted Therapy of Metastatic Pancreatic Adenocarcinoma: First Clinical Results
      Richard P. Baum, Aviral Singh, Christiane Schuchardt, Harshad R. Kulkarni, Ingo Klette, Stefan Wiessalla, Frank Osterkamp, Ulrich Reineke and Christiane Smerling
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 809-814; DOI: https://doi.org/10.2967/jnumed.117.193847

L

  1. Lammers, Twan

    1. Advanced Ultrasound Technologies for Diagnosis and Therapy
      Anne Rix, Wiltrud Lederle, Benjamin Theek, Twan Lammers, Chrit Moonen, Georg Schmitz and Fabian Kiessling
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 740-746; DOI: https://doi.org/10.2967/jnumed.117.200030

  2. Lapa, Constantin

    1. Predictive Value of 18F-FDG PET in Patients with Advanced Medullary Thyroid Carcinoma Treated with Vandetanib
      Rudolf A. Werner, Jan-Stefan Schmid, Takahiro Higuchi, Mehrbod S. Javadi, Steven P. Rowe, Bruno Märkl, Christoph Aulmann, Martin Fassnacht, Matthias Kroiss, Christoph Reiners, Andreas K. Buck, Michael C. Kreissl and Constantin Lapa
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 756-761; DOI: https://doi.org/10.2967/jnumed.117.199778
    2. Functional Renal Imaging with 2-Deoxy-2-18F-Fluorosorbitol PET in Rat Models of Renal Disorders
      Rudolf A. Werner, Hiroshi Wakabayashi, Xinyu Chen, Mitsuru Hirano, Tetsuya Shinaji, Constantin Lapa, Steven P. Rowe, Mehrbod S. Javadi and Takahiro Higuchi
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 828-832; DOI: https://doi.org/10.2967/jnumed.117.203828

  3. Larson, Peder E.Z.

    1. Zero-Echo-Time and Dixon Deep Pseudo-CT (ZeDD CT): Direct Generation of Pseudo-CT Images for Pelvic PET/MRI Attenuation Correction Using Deep Convolutional Neural Networks with Multiparametric MRI
      Andrew P. Leynes, Jaewon Yang, Florian Wiesinger, Sandeep S. Kaushik, Dattesh D. Shanbhag, Youngho Seo, Thomas A. Hope and Peder E.Z. Larson
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 852-858; DOI: https://doi.org/10.2967/jnumed.117.198051

  4. Lederle, Wiltrud

    1. Advanced Ultrasound Technologies for Diagnosis and Therapy
      Anne Rix, Wiltrud Lederle, Benjamin Theek, Twan Lammers, Chrit Moonen, Georg Schmitz and Fabian Kiessling
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 740-746; DOI: https://doi.org/10.2967/jnumed.117.200030

  5. Lee, Yun-Sang

    1. 18F-FEDAC as a Targeting Agent for Activated Macrophages in DBA/1 Mice with Collagen-Induced Arthritis: Comparison with 18F-FDG
      Seock-Jin Chung, Hai-Jeon Yoon, Hyewon Youn, Mi Jeong Kim, Yun-Sang Lee, Jae Min Jeong, June-Key Chung, Keon Wook Kang, Lin Xie, Ming-Rong Zhang and Gi Jeong Cheon
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 839-845; DOI: https://doi.org/10.2967/jnumed.117.200667

  6. Leynes, Andrew P.

    1. Zero-Echo-Time and Dixon Deep Pseudo-CT (ZeDD CT): Direct Generation of Pseudo-CT Images for Pelvic PET/MRI Attenuation Correction Using Deep Convolutional Neural Networks with Multiparametric MRI
      Andrew P. Leynes, Jaewon Yang, Florian Wiesinger, Sandeep S. Kaushik, Dattesh D. Shanbhag, Youngho Seo, Thomas A. Hope and Peder E.Z. Larson
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 852-858; DOI: https://doi.org/10.2967/jnumed.117.198051

  7. Loening, Andreas

    1. Prospective Evaluation of 68Ga-RM2 PET/MRI in Patients with Biochemical Recurrence of Prostate Cancer and Negative Findings on Conventional Imaging
      Ryogo Minamimoto, Ida Sonni, Steven Hancock, Shreyas Vasanawala, Andreas Loening, Sanjiv S. Gambhir and Andrei Iagaru
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 803-808; DOI: https://doi.org/10.2967/jnumed.117.197624

  8. Lub-de Hooge, Marjolijn N.

    1. Molecular Imaging in Cancer Drug Development
      Stijn J.H. Waaijer, Iris C. Kok, Bertha Eisses, Carolina P. Schröder, Mathilde Jalving, Adrienne H. Brouwers, Marjolijn N. Lub-de Hooge and Elisabeth G.E. de Vries
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 726-732; DOI: https://doi.org/10.2967/jnumed.116.188045

M

  1. Mahajan, Aparna M.

    1. Sex as a Biologic Variable in Preclinical Imaging Research: Initial Observations with 18F-FLT
      Szeman Ruby Chan, Kelley Salem, Justin Jeffery, Ginny L. Powers, Yongjun Yan, Kooresh I. Shoghi, Aparna M. Mahajan and Amy M. Fowler
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 833-838; DOI: https://doi.org/10.2967/jnumed.117.199406

  2. Märkl, Bruno

    1. Predictive Value of 18F-FDG PET in Patients with Advanced Medullary Thyroid Carcinoma Treated with Vandetanib
      Rudolf A. Werner, Jan-Stefan Schmid, Takahiro Higuchi, Mehrbod S. Javadi, Steven P. Rowe, Bruno Märkl, Christoph Aulmann, Martin Fassnacht, Matthias Kroiss, Christoph Reiners, Andreas K. Buck, Michael C. Kreissl and Constantin Lapa
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 756-761; DOI: https://doi.org/10.2967/jnumed.117.199778

  3. Michl, Marlies

    1. Prediction of 90Y Radioembolization Outcome from Pretherapeutic Factors with Random Survival Forests
      Michael Ingrisch, Franziska Schöppe, Karolin Paprottka, Matthias Fabritius, Frederik F. Strobl, Enrico N. De Toni, Harun Ilhan, Andrei Todica, Marlies Michl and Philipp Marius Paprottka
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 769-773; DOI: https://doi.org/10.2967/jnumed.117.200758

  4. Minamimoto, Ryogo

    1. Prospective Evaluation of 68Ga-RM2 PET/MRI in Patients with Biochemical Recurrence of Prostate Cancer and Negative Findings on Conventional Imaging
      Ryogo Minamimoto, Ida Sonni, Steven Hancock, Shreyas Vasanawala, Andreas Loening, Sanjiv S. Gambhir and Andrei Iagaru
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 803-808; DOI: https://doi.org/10.2967/jnumed.117.197624

  5. Moestue, Siver A.

    1. Combined 18F-Fluciclovine PET/MRI Shows Potential for Detection and Characterization of High-Risk Prostate Cancer
      Mattijs Elschot, Kirsten M. Selnæs, Elise Sandsmark, Brage Krüger-Stokke, Øystein Størkersen, Guro F. Giskeødegård, May-Britt Tessem, Siver A. Moestue, Helena Bertilsson and Tone F. Bathen
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 762-768; DOI: https://doi.org/10.2967/jnumed.117.198598

  6. Moonen, Chrit

    1. Advanced Ultrasound Technologies for Diagnosis and Therapy
      Anne Rix, Wiltrud Lederle, Benjamin Theek, Twan Lammers, Chrit Moonen, Georg Schmitz and Fabian Kiessling
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 740-746; DOI: https://doi.org/10.2967/jnumed.117.200030

  7. Morgenstern, Alfred

    1. Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with 225Ac-PSMA-617: Swimmer-Plot Analysis Suggests Efficacy Regarding Duration of Tumor Control
      Clemens Kratochwil, Frank Bruchertseifer, Hendrik Rathke, Markus Hohenfellner, Frederik L. Giesel, Uwe Haberkorn and Alfred Morgenstern
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 795-802; DOI: https://doi.org/10.2967/jnumed.117.203539

  8. Murphy, Robert C.

    1. 18F-FDG PET/CT in Erdheim–Chester Disease: Imaging Findings and Potential BRAF Mutation Biomarker
      Jason R. Young, Geoffrey B. Johnson, Robert C. Murphy, Ronald S. Go and Stephen M. Broski
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 774-779; DOI: https://doi.org/10.2967/jnumed.117.200741

N

  1. Nagarajah, James

    1. Digitalislike Compounds Restore hNIS Expression and Iodide Uptake Capacity in Anaplastic Thyroid Cancer
      Marika H. Tesselaar, Thomas Crezee, Imke Schuurmans, Danny Gerrits, James Nagarajah, Otto C. Boerman, Ilse van Engen–van Grunsven, Johannes W.A. Smit, Romana T. Netea–Maier and Theo S. Plantinga
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 780-786; DOI: https://doi.org/10.2967/jnumed.117.200675

  2. Nakamoto, Ryusuke

    1. Comparison of PET/CT with Sequential PET/MRI Using an MR-Compatible Mobile PET System
      Ryusuke Nakamoto, Yuji Nakamoto, Takayoshi Ishimori, Yasutaka Fushimi, Aki Kido and Kaori Togashi
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 846-851; DOI: https://doi.org/10.2967/jnumed.117.197665

  3. Nakamoto, Yuji

    1. Comparison of PET/CT with Sequential PET/MRI Using an MR-Compatible Mobile PET System
      Ryusuke Nakamoto, Yuji Nakamoto, Takayoshi Ishimori, Yasutaka Fushimi, Aki Kido and Kaori Togashi
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 846-851; DOI: https://doi.org/10.2967/jnumed.117.197665

  4. Netea–Maier, Romana T.

    1. Digitalislike Compounds Restore hNIS Expression and Iodide Uptake Capacity in Anaplastic Thyroid Cancer
      Marika H. Tesselaar, Thomas Crezee, Imke Schuurmans, Danny Gerrits, James Nagarajah, Otto C. Boerman, Ilse van Engen–van Grunsven, Johannes W.A. Smit, Romana T. Netea–Maier and Theo S. Plantinga
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 780-786; DOI: https://doi.org/10.2967/jnumed.117.200675

O

  1. Osterkamp, Frank

    1. 177Lu-3BP-227 for Neurotensin Receptor 1–Targeted Therapy of Metastatic Pancreatic Adenocarcinoma: First Clinical Results
      Richard P. Baum, Aviral Singh, Christiane Schuchardt, Harshad R. Kulkarni, Ingo Klette, Stefan Wiessalla, Frank Osterkamp, Ulrich Reineke and Christiane Smerling
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 809-814; DOI: https://doi.org/10.2967/jnumed.117.193847

P

  1. Pappas, Virginia

    1. SNMMI Leadership Update: A Strong SNMMI
      Virginia Pappas
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 12N;

  2. Paprottka, Karolin

    1. Prediction of 90Y Radioembolization Outcome from Pretherapeutic Factors with Random Survival Forests
      Michael Ingrisch, Franziska Schöppe, Karolin Paprottka, Matthias Fabritius, Frederik F. Strobl, Enrico N. De Toni, Harun Ilhan, Andrei Todica, Marlies Michl and Philipp Marius Paprottka
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 769-773; DOI: https://doi.org/10.2967/jnumed.117.200758

  3. Paprottka, Philipp Marius

    1. Prediction of 90Y Radioembolization Outcome from Pretherapeutic Factors with Random Survival Forests
      Michael Ingrisch, Franziska Schöppe, Karolin Paprottka, Matthias Fabritius, Frederik F. Strobl, Enrico N. De Toni, Harun Ilhan, Andrei Todica, Marlies Michl and Philipp Marius Paprottka
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 769-773; DOI: https://doi.org/10.2967/jnumed.117.200758

  4. Parent, Ephraim E.

    1. Update on 18F-Fluciclovine PET for Prostate Cancer Imaging
      Ephraim E. Parent and David M. Schuster
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 733-739; DOI: https://doi.org/10.2967/jnumed.117.204032

  5. Pattison, David A.

    1. 18F-FDG–Avid Thyroid Incidentalomas: The Importance of Contextual Interpretation
      David A. Pattison, Michael Bozin, Alexandra Gorelik, Michael S. Hofman, Rodney J. Hicks and Anita Skandarajah
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 749-755; DOI: https://doi.org/10.2967/jnumed.117.198085

  6. Plantinga, Theo S.

    1. Digitalislike Compounds Restore hNIS Expression and Iodide Uptake Capacity in Anaplastic Thyroid Cancer
      Marika H. Tesselaar, Thomas Crezee, Imke Schuurmans, Danny Gerrits, James Nagarajah, Otto C. Boerman, Ilse van Engen–van Grunsven, Johannes W.A. Smit, Romana T. Netea–Maier and Theo S. Plantinga
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 780-786; DOI: https://doi.org/10.2967/jnumed.117.200675

  7. Pomper, Martin G.

    1. Molecular Imaging of Prostate Cancer: Choosing the Right Agent
      Steven P. Rowe, Martin G. Pomper and Michael A. Gorin
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 787-788; DOI: https://doi.org/10.2967/jnumed.117.206318

  8. Powers, Ginny L.

    1. Sex as a Biologic Variable in Preclinical Imaging Research: Initial Observations with 18F-FLT
      Szeman Ruby Chan, Kelley Salem, Justin Jeffery, Ginny L. Powers, Yongjun Yan, Kooresh I. Shoghi, Aparna M. Mahajan and Amy M. Fowler
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 833-838; DOI: https://doi.org/10.2967/jnumed.117.199406

R

  1. Rathke, Hendrik

    1. Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with 225Ac-PSMA-617: Swimmer-Plot Analysis Suggests Efficacy Regarding Duration of Tumor Control
      Clemens Kratochwil, Frank Bruchertseifer, Hendrik Rathke, Markus Hohenfellner, Frederik L. Giesel, Uwe Haberkorn and Alfred Morgenstern
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 795-802; DOI: https://doi.org/10.2967/jnumed.117.203539

  2. Reineke, Ulrich

    1. 177Lu-3BP-227 for Neurotensin Receptor 1–Targeted Therapy of Metastatic Pancreatic Adenocarcinoma: First Clinical Results
      Richard P. Baum, Aviral Singh, Christiane Schuchardt, Harshad R. Kulkarni, Ingo Klette, Stefan Wiessalla, Frank Osterkamp, Ulrich Reineke and Christiane Smerling
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 809-814; DOI: https://doi.org/10.2967/jnumed.117.193847

  3. Reiners, Christoph

    1. Predictive Value of 18F-FDG PET in Patients with Advanced Medullary Thyroid Carcinoma Treated with Vandetanib
      Rudolf A. Werner, Jan-Stefan Schmid, Takahiro Higuchi, Mehrbod S. Javadi, Steven P. Rowe, Bruno Märkl, Christoph Aulmann, Martin Fassnacht, Matthias Kroiss, Christoph Reiners, Andreas K. Buck, Michael C. Kreissl and Constantin Lapa
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 756-761; DOI: https://doi.org/10.2967/jnumed.117.199778

  4. Rix, Anne

    1. Advanced Ultrasound Technologies for Diagnosis and Therapy
      Anne Rix, Wiltrud Lederle, Benjamin Theek, Twan Lammers, Chrit Moonen, Georg Schmitz and Fabian Kiessling
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 740-746; DOI: https://doi.org/10.2967/jnumed.117.200030

  5. Rocchi, Palma

    1. PSMA-Targeted Radionuclide Therapy and Salivary Gland Toxicity: Why Does It Matter?
      David Taïeb, Jean-Marc Foletti, Manuel Bardiès, Palma Rocchi, Rodney J. Hicks and Uwe Haberkorn
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 747-748; DOI: https://doi.org/10.2967/jnumed.118.207993

  6. Rowe, Steven P.

    1. Molecular Imaging of Prostate Cancer: Choosing the Right Agent
      Steven P. Rowe, Martin G. Pomper and Michael A. Gorin
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 787-788; DOI: https://doi.org/10.2967/jnumed.117.206318
    2. Predictive Value of 18F-FDG PET in Patients with Advanced Medullary Thyroid Carcinoma Treated with Vandetanib
      Rudolf A. Werner, Jan-Stefan Schmid, Takahiro Higuchi, Mehrbod S. Javadi, Steven P. Rowe, Bruno Märkl, Christoph Aulmann, Martin Fassnacht, Matthias Kroiss, Christoph Reiners, Andreas K. Buck, Michael C. Kreissl and Constantin Lapa
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 756-761; DOI: https://doi.org/10.2967/jnumed.117.199778
    3. Functional Renal Imaging with 2-Deoxy-2-18F-Fluorosorbitol PET in Rat Models of Renal Disorders
      Rudolf A. Werner, Hiroshi Wakabayashi, Xinyu Chen, Mitsuru Hirano, Tetsuya Shinaji, Constantin Lapa, Steven P. Rowe, Mehrbod S. Javadi and Takahiro Higuchi
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 828-832; DOI: https://doi.org/10.2967/jnumed.117.203828

S

  1. Salem, Kelley

    1. Sex as a Biologic Variable in Preclinical Imaging Research: Initial Observations with 18F-FLT
      Szeman Ruby Chan, Kelley Salem, Justin Jeffery, Ginny L. Powers, Yongjun Yan, Kooresh I. Shoghi, Aparna M. Mahajan and Amy M. Fowler
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 833-838; DOI: https://doi.org/10.2967/jnumed.117.199406

  2. Sandsmark, Elise

    1. Combined 18F-Fluciclovine PET/MRI Shows Potential for Detection and Characterization of High-Risk Prostate Cancer
      Mattijs Elschot, Kirsten M. Selnæs, Elise Sandsmark, Brage Krüger-Stokke, Øystein Størkersen, Guro F. Giskeødegård, May-Britt Tessem, Siver A. Moestue, Helena Bertilsson and Tone F. Bathen
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 762-768; DOI: https://doi.org/10.2967/jnumed.117.198598

  3. Schmid, Jan-Stefan

    1. Predictive Value of 18F-FDG PET in Patients with Advanced Medullary Thyroid Carcinoma Treated with Vandetanib
      Rudolf A. Werner, Jan-Stefan Schmid, Takahiro Higuchi, Mehrbod S. Javadi, Steven P. Rowe, Bruno Märkl, Christoph Aulmann, Martin Fassnacht, Matthias Kroiss, Christoph Reiners, Andreas K. Buck, Michael C. Kreissl and Constantin Lapa
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 756-761; DOI: https://doi.org/10.2967/jnumed.117.199778

  4. Schmitz, Georg

    1. Advanced Ultrasound Technologies for Diagnosis and Therapy
      Anne Rix, Wiltrud Lederle, Benjamin Theek, Twan Lammers, Chrit Moonen, Georg Schmitz and Fabian Kiessling
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 740-746; DOI: https://doi.org/10.2967/jnumed.117.200030

  5. Schöppe, Franziska

    1. Prediction of 90Y Radioembolization Outcome from Pretherapeutic Factors with Random Survival Forests
      Michael Ingrisch, Franziska Schöppe, Karolin Paprottka, Matthias Fabritius, Frederik F. Strobl, Enrico N. De Toni, Harun Ilhan, Andrei Todica, Marlies Michl and Philipp Marius Paprottka
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 769-773; DOI: https://doi.org/10.2967/jnumed.117.200758

  6. Schröder, Carolina P.

    1. Molecular Imaging in Cancer Drug Development
      Stijn J.H. Waaijer, Iris C. Kok, Bertha Eisses, Carolina P. Schröder, Mathilde Jalving, Adrienne H. Brouwers, Marjolijn N. Lub-de Hooge and Elisabeth G.E. de Vries
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 726-732; DOI: https://doi.org/10.2967/jnumed.116.188045

  7. Schuchardt, Christiane

    1. 177Lu-3BP-227 for Neurotensin Receptor 1–Targeted Therapy of Metastatic Pancreatic Adenocarcinoma: First Clinical Results
      Richard P. Baum, Aviral Singh, Christiane Schuchardt, Harshad R. Kulkarni, Ingo Klette, Stefan Wiessalla, Frank Osterkamp, Ulrich Reineke and Christiane Smerling
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 809-814; DOI: https://doi.org/10.2967/jnumed.117.193847

  8. Schuster, David M.

    1. Update on 18F-Fluciclovine PET for Prostate Cancer Imaging
      Ephraim E. Parent and David M. Schuster
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 733-739; DOI: https://doi.org/10.2967/jnumed.117.204032

  9. Schuurmans, Imke

    1. Digitalislike Compounds Restore hNIS Expression and Iodide Uptake Capacity in Anaplastic Thyroid Cancer
      Marika H. Tesselaar, Thomas Crezee, Imke Schuurmans, Danny Gerrits, James Nagarajah, Otto C. Boerman, Ilse van Engen–van Grunsven, Johannes W.A. Smit, Romana T. Netea–Maier and Theo S. Plantinga
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 780-786; DOI: https://doi.org/10.2967/jnumed.117.200675

  10. Selnæs, Kirsten M.

    1. Combined 18F-Fluciclovine PET/MRI Shows Potential for Detection and Characterization of High-Risk Prostate Cancer
      Mattijs Elschot, Kirsten M. Selnæs, Elise Sandsmark, Brage Krüger-Stokke, Øystein Størkersen, Guro F. Giskeødegård, May-Britt Tessem, Siver A. Moestue, Helena Bertilsson and Tone F. Bathen
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 762-768; DOI: https://doi.org/10.2967/jnumed.117.198598

  11. Seo, Youngho

    1. Zero-Echo-Time and Dixon Deep Pseudo-CT (ZeDD CT): Direct Generation of Pseudo-CT Images for Pelvic PET/MRI Attenuation Correction Using Deep Convolutional Neural Networks with Multiparametric MRI
      Andrew P. Leynes, Jaewon Yang, Florian Wiesinger, Sandeep S. Kaushik, Dattesh D. Shanbhag, Youngho Seo, Thomas A. Hope and Peder E.Z. Larson
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 852-858; DOI: https://doi.org/10.2967/jnumed.117.198051

  12. Sgouros, George

    1. Wessels to Be Recognized with Loevinger–Berman Award
      Roger W. Howell and George Sgouros; on behalf of the SNMMI Medical Internal Radiation Dose Committee
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 9N-10N;

  13. Shanbhag, Dattesh D.

    1. Zero-Echo-Time and Dixon Deep Pseudo-CT (ZeDD CT): Direct Generation of Pseudo-CT Images for Pelvic PET/MRI Attenuation Correction Using Deep Convolutional Neural Networks with Multiparametric MRI
      Andrew P. Leynes, Jaewon Yang, Florian Wiesinger, Sandeep S. Kaushik, Dattesh D. Shanbhag, Youngho Seo, Thomas A. Hope and Peder E.Z. Larson
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 852-858; DOI: https://doi.org/10.2967/jnumed.117.198051

  14. Sharp, David J.

    1. Spatiotemporal Distribution of β-Amyloid in Alzheimer Disease Is the Result of Heterogeneous Regional Carrying Capacities
      Alex Whittington, David J. Sharp and Roger N. Gunn; for the Alzheimer’s Disease Neuroimaging Initiative
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 822-827; DOI: https://doi.org/10.2967/jnumed.117.194720

  15. Shinaji, Tetsuya

    1. Functional Renal Imaging with 2-Deoxy-2-18F-Fluorosorbitol PET in Rat Models of Renal Disorders
      Rudolf A. Werner, Hiroshi Wakabayashi, Xinyu Chen, Mitsuru Hirano, Tetsuya Shinaji, Constantin Lapa, Steven P. Rowe, Mehrbod S. Javadi and Takahiro Higuchi
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 828-832; DOI: https://doi.org/10.2967/jnumed.117.203828

  16. Shoghi, Kooresh I.

    1. Sex as a Biologic Variable in Preclinical Imaging Research: Initial Observations with 18F-FLT
      Szeman Ruby Chan, Kelley Salem, Justin Jeffery, Ginny L. Powers, Yongjun Yan, Kooresh I. Shoghi, Aparna M. Mahajan and Amy M. Fowler
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 833-838; DOI: https://doi.org/10.2967/jnumed.117.199406

  17. Siegel, Jeffry A.

    1. RADAR Develops New Generation of Dosimetry Phantoms
      Michael G. Stabin, Jeffry A. Siegel and X. George Xu; for the RAdiation Dose Assessment Resource Committee of the SNMMI
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 11N;

  18. Singh, Aviral

    1. 177Lu-3BP-227 for Neurotensin Receptor 1–Targeted Therapy of Metastatic Pancreatic Adenocarcinoma: First Clinical Results
      Richard P. Baum, Aviral Singh, Christiane Schuchardt, Harshad R. Kulkarni, Ingo Klette, Stefan Wiessalla, Frank Osterkamp, Ulrich Reineke and Christiane Smerling
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 809-814; DOI: https://doi.org/10.2967/jnumed.117.193847

  19. Skandarajah, Anita

    1. 18F-FDG–Avid Thyroid Incidentalomas: The Importance of Contextual Interpretation
      David A. Pattison, Michael Bozin, Alexandra Gorelik, Michael S. Hofman, Rodney J. Hicks and Anita Skandarajah
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 749-755; DOI: https://doi.org/10.2967/jnumed.117.198085

  20. Smerling, Christiane

    1. 177Lu-3BP-227 for Neurotensin Receptor 1–Targeted Therapy of Metastatic Pancreatic Adenocarcinoma: First Clinical Results
      Richard P. Baum, Aviral Singh, Christiane Schuchardt, Harshad R. Kulkarni, Ingo Klette, Stefan Wiessalla, Frank Osterkamp, Ulrich Reineke and Christiane Smerling
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 809-814; DOI: https://doi.org/10.2967/jnumed.117.193847

  21. Smit, Johannes W.A.

    1. Digitalislike Compounds Restore hNIS Expression and Iodide Uptake Capacity in Anaplastic Thyroid Cancer
      Marika H. Tesselaar, Thomas Crezee, Imke Schuurmans, Danny Gerrits, James Nagarajah, Otto C. Boerman, Ilse van Engen–van Grunsven, Johannes W.A. Smit, Romana T. Netea–Maier and Theo S. Plantinga
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 780-786; DOI: https://doi.org/10.2967/jnumed.117.200675

  22. Sonni, Ida

    1. Prospective Evaluation of 68Ga-RM2 PET/MRI in Patients with Biochemical Recurrence of Prostate Cancer and Negative Findings on Conventional Imaging
      Ryogo Minamimoto, Ida Sonni, Steven Hancock, Shreyas Vasanawala, Andreas Loening, Sanjiv S. Gambhir and Andrei Iagaru
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 803-808; DOI: https://doi.org/10.2967/jnumed.117.197624

  23. Stabin, Michael G.

    1. RADAR Develops New Generation of Dosimetry Phantoms
      Michael G. Stabin, Jeffry A. Siegel and X. George Xu; for the RAdiation Dose Assessment Resource Committee of the SNMMI
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 11N;

  24. Størkersen, Øystein

    1. Combined 18F-Fluciclovine PET/MRI Shows Potential for Detection and Characterization of High-Risk Prostate Cancer
      Mattijs Elschot, Kirsten M. Selnæs, Elise Sandsmark, Brage Krüger-Stokke, Øystein Størkersen, Guro F. Giskeødegård, May-Britt Tessem, Siver A. Moestue, Helena Bertilsson and Tone F. Bathen
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 762-768; DOI: https://doi.org/10.2967/jnumed.117.198598

  25. Strobl, Frederik F.

    1. Prediction of 90Y Radioembolization Outcome from Pretherapeutic Factors with Random Survival Forests
      Michael Ingrisch, Franziska Schöppe, Karolin Paprottka, Matthias Fabritius, Frederik F. Strobl, Enrico N. De Toni, Harun Ilhan, Andrei Todica, Marlies Michl and Philipp Marius Paprottka
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 769-773; DOI: https://doi.org/10.2967/jnumed.117.200758

T

  1. Taïeb, David

    1. PSMA-Targeted Radionuclide Therapy and Salivary Gland Toxicity: Why Does It Matter?
      David Taïeb, Jean-Marc Foletti, Manuel Bardiès, Palma Rocchi, Rodney J. Hicks and Uwe Haberkorn
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 747-748; DOI: https://doi.org/10.2967/jnumed.118.207993

  2. Tesselaar, Marika H.

    1. Digitalislike Compounds Restore hNIS Expression and Iodide Uptake Capacity in Anaplastic Thyroid Cancer
      Marika H. Tesselaar, Thomas Crezee, Imke Schuurmans, Danny Gerrits, James Nagarajah, Otto C. Boerman, Ilse van Engen–van Grunsven, Johannes W.A. Smit, Romana T. Netea–Maier and Theo S. Plantinga
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 780-786; DOI: https://doi.org/10.2967/jnumed.117.200675

  3. Tessem, May-Britt

    1. Combined 18F-Fluciclovine PET/MRI Shows Potential for Detection and Characterization of High-Risk Prostate Cancer
      Mattijs Elschot, Kirsten M. Selnæs, Elise Sandsmark, Brage Krüger-Stokke, Øystein Størkersen, Guro F. Giskeødegård, May-Britt Tessem, Siver A. Moestue, Helena Bertilsson and Tone F. Bathen
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 762-768; DOI: https://doi.org/10.2967/jnumed.117.198598

  4. Theek, Benjamin

    1. Advanced Ultrasound Technologies for Diagnosis and Therapy
      Anne Rix, Wiltrud Lederle, Benjamin Theek, Twan Lammers, Chrit Moonen, Georg Schmitz and Fabian Kiessling
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 740-746; DOI: https://doi.org/10.2967/jnumed.117.200030

  5. Todica, Andrei

    1. Prediction of 90Y Radioembolization Outcome from Pretherapeutic Factors with Random Survival Forests
      Michael Ingrisch, Franziska Schöppe, Karolin Paprottka, Matthias Fabritius, Frederik F. Strobl, Enrico N. De Toni, Harun Ilhan, Andrei Todica, Marlies Michl and Philipp Marius Paprottka
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 769-773; DOI: https://doi.org/10.2967/jnumed.117.200758

  6. Togashi, Kaori

    1. Comparison of PET/CT with Sequential PET/MRI Using an MR-Compatible Mobile PET System
      Ryusuke Nakamoto, Yuji Nakamoto, Takayoshi Ishimori, Yasutaka Fushimi, Aki Kido and Kaori Togashi
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 846-851; DOI: https://doi.org/10.2967/jnumed.117.197665

  7. Tsushima, Yoshito

    1. Radiolabeled (4-Fluoro-3-Iodobenzyl)Guanidine Improves Imaging and Targeted Radionuclide Therapy of Norepinephrine Transporter–Expressing Tumors
      Aiko Yamaguchi, Hirofumi Hanaoka, Tetsuya Higuchi and Yoshito Tsushima
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 815-821; DOI: https://doi.org/10.2967/jnumed.117.201525

  8. Tulchinsky, Mark

    1. Radioactive Iodine Therapy for Differentiated Thyroid Cancer: Lessons from Confronting Controversial Literature on Risks for Secondary Malignancy
      Mark Tulchinsky, Ina Binse, Alfredo Campennì, Sabina Dizdarevic, Luca Giovanella, Ian Jong, Kalevi Kairemo and Chun K. Kim
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 723-725; DOI: https://doi.org/10.2967/jnumed.118.211359

V

  1. van Engen–van Grunsven, Ilse

    1. Digitalislike Compounds Restore hNIS Expression and Iodide Uptake Capacity in Anaplastic Thyroid Cancer
      Marika H. Tesselaar, Thomas Crezee, Imke Schuurmans, Danny Gerrits, James Nagarajah, Otto C. Boerman, Ilse van Engen–van Grunsven, Johannes W.A. Smit, Romana T. Netea–Maier and Theo S. Plantinga
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 780-786; DOI: https://doi.org/10.2967/jnumed.117.200675

  2. Vasanawala, Shreyas

    1. Prospective Evaluation of 68Ga-RM2 PET/MRI in Patients with Biochemical Recurrence of Prostate Cancer and Negative Findings on Conventional Imaging
      Ryogo Minamimoto, Ida Sonni, Steven Hancock, Shreyas Vasanawala, Andreas Loening, Sanjiv S. Gambhir and Andrei Iagaru
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 803-808; DOI: https://doi.org/10.2967/jnumed.117.197624

W

  1. Waaijer, Stijn J.H.

    1. Molecular Imaging in Cancer Drug Development
      Stijn J.H. Waaijer, Iris C. Kok, Bertha Eisses, Carolina P. Schröder, Mathilde Jalving, Adrienne H. Brouwers, Marjolijn N. Lub-de Hooge and Elisabeth G.E. de Vries
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 726-732; DOI: https://doi.org/10.2967/jnumed.116.188045

  2. Wakabayashi, Hiroshi

    1. Functional Renal Imaging with 2-Deoxy-2-18F-Fluorosorbitol PET in Rat Models of Renal Disorders
      Rudolf A. Werner, Hiroshi Wakabayashi, Xinyu Chen, Mitsuru Hirano, Tetsuya Shinaji, Constantin Lapa, Steven P. Rowe, Mehrbod S. Javadi and Takahiro Higuchi
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 828-832; DOI: https://doi.org/10.2967/jnumed.117.203828

  3. Werner, Rudolf A.

    1. Predictive Value of 18F-FDG PET in Patients with Advanced Medullary Thyroid Carcinoma Treated with Vandetanib
      Rudolf A. Werner, Jan-Stefan Schmid, Takahiro Higuchi, Mehrbod S. Javadi, Steven P. Rowe, Bruno Märkl, Christoph Aulmann, Martin Fassnacht, Matthias Kroiss, Christoph Reiners, Andreas K. Buck, Michael C. Kreissl and Constantin Lapa
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 756-761; DOI: https://doi.org/10.2967/jnumed.117.199778
    2. Functional Renal Imaging with 2-Deoxy-2-18F-Fluorosorbitol PET in Rat Models of Renal Disorders
      Rudolf A. Werner, Hiroshi Wakabayashi, Xinyu Chen, Mitsuru Hirano, Tetsuya Shinaji, Constantin Lapa, Steven P. Rowe, Mehrbod S. Javadi and Takahiro Higuchi
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 828-832; DOI: https://doi.org/10.2967/jnumed.117.203828

  4. Whittington, Alex

    1. Spatiotemporal Distribution of β-Amyloid in Alzheimer Disease Is the Result of Heterogeneous Regional Carrying Capacities
      Alex Whittington, David J. Sharp and Roger N. Gunn; for the Alzheimer’s Disease Neuroimaging Initiative
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 822-827; DOI: https://doi.org/10.2967/jnumed.117.194720

  5. Wiesinger, Florian

    1. Zero-Echo-Time and Dixon Deep Pseudo-CT (ZeDD CT): Direct Generation of Pseudo-CT Images for Pelvic PET/MRI Attenuation Correction Using Deep Convolutional Neural Networks with Multiparametric MRI
      Andrew P. Leynes, Jaewon Yang, Florian Wiesinger, Sandeep S. Kaushik, Dattesh D. Shanbhag, Youngho Seo, Thomas A. Hope and Peder E.Z. Larson
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 852-858; DOI: https://doi.org/10.2967/jnumed.117.198051

  6. Wiessalla, Stefan

    1. 177Lu-3BP-227 for Neurotensin Receptor 1–Targeted Therapy of Metastatic Pancreatic Adenocarcinoma: First Clinical Results
      Richard P. Baum, Aviral Singh, Christiane Schuchardt, Harshad R. Kulkarni, Ingo Klette, Stefan Wiessalla, Frank Osterkamp, Ulrich Reineke and Christiane Smerling
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 809-814; DOI: https://doi.org/10.2967/jnumed.117.193847

X

  1. Xie, Lin

    1. 18F-FEDAC as a Targeting Agent for Activated Macrophages in DBA/1 Mice with Collagen-Induced Arthritis: Comparison with 18F-FDG
      Seock-Jin Chung, Hai-Jeon Yoon, Hyewon Youn, Mi Jeong Kim, Yun-Sang Lee, Jae Min Jeong, June-Key Chung, Keon Wook Kang, Lin Xie, Ming-Rong Zhang and Gi Jeong Cheon
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 839-845; DOI: https://doi.org/10.2967/jnumed.117.200667

  2. Xu, X. George

    1. RADAR Develops New Generation of Dosimetry Phantoms
      Michael G. Stabin, Jeffry A. Siegel and X. George Xu; for the RAdiation Dose Assessment Resource Committee of the SNMMI
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 11N;

Y

  1. Yamaguchi, Aiko

    1. Radiolabeled (4-Fluoro-3-Iodobenzyl)Guanidine Improves Imaging and Targeted Radionuclide Therapy of Norepinephrine Transporter–Expressing Tumors
      Aiko Yamaguchi, Hirofumi Hanaoka, Tetsuya Higuchi and Yoshito Tsushima
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 815-821; DOI: https://doi.org/10.2967/jnumed.117.201525

  2. Yan, Yongjun

    1. Sex as a Biologic Variable in Preclinical Imaging Research: Initial Observations with 18F-FLT
      Szeman Ruby Chan, Kelley Salem, Justin Jeffery, Ginny L. Powers, Yongjun Yan, Kooresh I. Shoghi, Aparna M. Mahajan and Amy M. Fowler
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 833-838; DOI: https://doi.org/10.2967/jnumed.117.199406

  3. Yang, Jaewon

    1. Zero-Echo-Time and Dixon Deep Pseudo-CT (ZeDD CT): Direct Generation of Pseudo-CT Images for Pelvic PET/MRI Attenuation Correction Using Deep Convolutional Neural Networks with Multiparametric MRI
      Andrew P. Leynes, Jaewon Yang, Florian Wiesinger, Sandeep S. Kaushik, Dattesh D. Shanbhag, Youngho Seo, Thomas A. Hope and Peder E.Z. Larson
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 852-858; DOI: https://doi.org/10.2967/jnumed.117.198051

  4. Yoon, Hai-Jeon

    1. 18F-FEDAC as a Targeting Agent for Activated Macrophages in DBA/1 Mice with Collagen-Induced Arthritis: Comparison with 18F-FDG
      Seock-Jin Chung, Hai-Jeon Yoon, Hyewon Youn, Mi Jeong Kim, Yun-Sang Lee, Jae Min Jeong, June-Key Chung, Keon Wook Kang, Lin Xie, Ming-Rong Zhang and Gi Jeong Cheon
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 839-845; DOI: https://doi.org/10.2967/jnumed.117.200667

  5. Youn, Hyewon

    1. 18F-FEDAC as a Targeting Agent for Activated Macrophages in DBA/1 Mice with Collagen-Induced Arthritis: Comparison with 18F-FDG
      Seock-Jin Chung, Hai-Jeon Yoon, Hyewon Youn, Mi Jeong Kim, Yun-Sang Lee, Jae Min Jeong, June-Key Chung, Keon Wook Kang, Lin Xie, Ming-Rong Zhang and Gi Jeong Cheon
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 839-845; DOI: https://doi.org/10.2967/jnumed.117.200667

  6. Young, Jason R.

    1. 18F-FDG PET/CT in Erdheim–Chester Disease: Imaging Findings and Potential BRAF Mutation Biomarker
      Jason R. Young, Geoffrey B. Johnson, Robert C. Murphy, Ronald S. Go and Stephen M. Broski
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 774-779; DOI: https://doi.org/10.2967/jnumed.117.200741

Z

  1. Zhang, Ming-Rong

    1. 18F-FEDAC as a Targeting Agent for Activated Macrophages in DBA/1 Mice with Collagen-Induced Arthritis: Comparison with 18F-FDG
      Seock-Jin Chung, Hai-Jeon Yoon, Hyewon Youn, Mi Jeong Kim, Yun-Sang Lee, Jae Min Jeong, June-Key Chung, Keon Wook Kang, Lin Xie, Ming-Rong Zhang and Gi Jeong Cheon
      Journal of Nuclear Medicine May 1, 2018, 59 (5) 839-845; DOI: https://doi.org/10.2967/jnumed.117.200667
Back to top

In this issue